Rare diseases
Investigational molecules
Locations
Back to Spain76 clinical trials in Ourense, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
SpainStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
SpainA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
SpainA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
SpainA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
SpainA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
SpainA study testing duvakitug for patients with moderately to severely active ulcerative colitis
SpainStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SpainStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
SpainStudy of ivonescimab plus enfortumab vedotin versus pembrolizumab plus enfortumab vedotin in previously untreated locally advanced or metastatic urothelial carcinoma
SpainStudy of PF-08634404 with chemotherapy drug combination in previously untreated patients with locally advanced or metastatic gastric and gastroesophageal adenocarcinoma
SpainStudy of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments across multiple types, including prostate, lung, and gastrointestinal cancers. Studies evaluate novel therapeutic combinations and targeted approaches.
Emphasis on personalized medicine approaches and immunotherapy combinations.
Research investigating treatments for various blood disorders and cancers, including multiple myeloma and lymphomas. Focus on targeted therapies and novel drug combinations.
Evaluating next-generation treatments for blood-related cancers.
Studies addressing urgent medical conditions including septic shock and respiratory infections. Research focuses on improving patient outcomes through innovative treatment protocols.
Development of enhanced treatment approaches for critical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
